Prazer Therapeutics is a leading pharmaceutical company with a mission to improve the lives of patients suffering from intractable diseases. We are dedicated to revolutionizing drug design through logical and innovative approaches. Our cutting-edge drug development platforms, including rational molecular drug design technology and next-generation protein degradation technology, allow us to target undruggable diseases and make them druggable. With a strong focus on addressing unmet medical needs, we strive to make incurable diseases curable.

Our team comprises top industry professionals and scientific advisors from prestigious institutions such as Kyung Hee University, Seoul National University, and Harvard Medical School. Together, we collaborate with partners to achieve our common goal of a healthy society without disease.

At Prazer Therapeutics, we are committed to pioneering breakthroughs in medicine and transforming the future of healthcare. Contact us today to learn more about our innovative products and services.